ZYME

Zymeworks Inc. Common Stock

Price

$29.79

return (12m)

110.68%

p/e

-10.80

p/bv

0.03

DIVIDEND YIELD

0.00%

ZYME price

Zymeworks Inc. Common Stock

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ZYME

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

26.07%

3 months

23.92%

1 year

110.68%

2 years

158.59%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ZYME

Valuation

P/E

-10.80

Sector -4.23

Industry -4.23

P/BV

0.03

Sector 2.11

Industry 2.11

P/Revenue (PSR)

55.61

Sector 2.05

Industry 2.05

EV/EBITDA

Sector -546.75

Industry -546.75

EV/EBIT

Sector -37.85

Industry -37.85

P/EBITDA

-19.32

Sector -51.33

Industry -51.33

P/EBIT

-1.65

Sector -39.56

Industry -39.56

P/Total Assets

0.01

Sector 1.25

Industry 1.25

P/Net Current Assets

-0.11

Sector -5.36

Industry -5.36

P/Working Capital

0.01

Sector -1.24

Industry -1.24

EPS

-2.62

Sector -1.92

Industry -1.92

BVPS

1,101.05

Sector 1.93

Industry 1.93

Efficiency

Gross Margin

75.41%

Sector 39.10%

Industry 39.10%

EBITDA Margin

Sector -13,872.36%

Industry -13,872.36%

EBIT Margin

-104.60%

Sector -4,235,733.26%

Industry -4,235,733.26%

Operating Margin

-100.00%

Sector -36.62%

Industry -36.62%

Net Profit Margins

-100.00%

Sector -37.41%

Industry -37.41%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-0.24%

Sector -60.49%

Industry -60.49%

ROA

-0.05%

Sector -63.06%

Industry -63.06%

ROIC

Sector -498.28%

Industry -498.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.32

Sector 2.90

Industry 2.90

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

Sector -38,821.65

Industry -38,821.65

Gross Debt / Equity

Sector -0.83

Industry -0.83

Equity/Assets

0.20

Sector 0.43

Industry 0.43

Liabilities/Assets

0.80

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

6.83%

Sector -

Industry -

5Y Earnings CAGR

-2.03%

Sector -

Industry -

Fundamentals ZYME

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ZYME Zymeworks Inc. Common Stock	$29.79	112.63%	0.00%	-10.80	0.03	-0.24%	-100.00%
JNJ Johnson & Johnson	$277.82	60.73%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.67	22.83%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$260.84	27.01%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.05	-12.95%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$151.13	83.70%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$164.27	2.46%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.65	49.46%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$75.60	-49.60%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$443.34	60.06%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$841.88	49.91%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.11	50.14%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$920.40	33.76%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$557.35	38.99%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$247.26	67.44%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$42.74	15.20%	0.00%	12.57	2.28	18.14%	18.89%
ARGX argenx SE	$1,061.23	50.23%	0.00%	3.11	3.48	112.18%	44.41%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ZYME Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Zymeworks Inc. Common Stock

Zymeworks Inc. Common Stock

Average Investor10 user rating

4.0 (0 people)

Canada

23 years

Founded: 2003

2017

Time since IPO - 9 years

231

Employees

Zymeworks Inc. Common Stock (Canada) is listed on the Nasdaq and has a market capitalization of $2.06 billion, with shareholders equity totaling $80.37 billion.

The company employs approximately 231 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Zymeworks Inc. Common Stock reported $37.13 million in revenue, generating net income of $-191.20 million.

Key financial metrics include a P/E ratio of -10.80, a price-to-book (P/B) ratio of 0.03, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ZYME.

Market cap

$2.06 billion

Net worth

$80.37 billion

$80,369,000,000.00

Assets

$396.96 billion

$396,964,000,000.00

Total Shares Outstanding

72.99 million

72,993,000

Average Daily Trading Volume

$688.03 Thousand

$688,030.00

Sector

Health Care

Industry

Biotechnology

ZYME

ZYME revenue and profits

Financial Results ZYME

DRAG THE FRAME TO SEE MORE DATA

ZYME cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$920.40 33,91% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$247.26 66,32% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$260.84 27,05% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$151.13 86,53% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$164.27 2,98% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.67 23,78% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$920.40 33,91% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$247.26 66,32% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$260.84 27,05% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$151.13 86,53% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$164.27 2,98% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.67 23,78% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Zymeworks Inc. Common Stock (ZYME) today?

A cotação de Zymeworks Inc. Common Stock (ZYME) hoje está em US$ 29.79, com uma variação de 110.68% em relação ao último ano. A cotação de Zymeworks Inc. Common Stock (ZYME) iniciou o ano negociando na casa dos US$ 26.33 e hoje está em US$ 29.79. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Zymeworks Inc. Common Stock (ZYME) e dados de ações do Ibovespa e mercados internacionais.

Quando Zymeworks Inc. Common Stock (ZYME) paga dividendos?

Zymeworks Inc. Common Stock (ZYME) não distribuiu dividendos no último ano.

Is Zymeworks Inc. Common Stock (ZYME) a good investment?

Atualmente, Zymeworks Inc. Common Stock (ZYME) está cotada a US$ 29.79, com um P/L de -10.80, representando um desvio de -743% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 110.68 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 110.68%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Zymeworks Inc. Common Stock (ZYME) stock?

Investir em ações de Zymeworks Inc. Common Stock (ZYME) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Zymeworks Inc. Common Stock (ZYME) yield today?

A rentabilidade de Zymeworks Inc. Common Stock (ZYME) foi de 26.07% no último mês, 110.68% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Zymeworks Inc. Common Stock (ZYME) hoje, o investimento total seria de US$ 2,979.00, com base na cotação atual de US$ 29.79.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 6,276.16
Em 5 anos: US$ 2,979.00
Em 10 anos: US$ 2,979.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ZYME

Zymeworks Inc. Common Stock

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ZYME

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ZYME WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Zymeworks Inc. Common Stock

Zymeworks Inc. Common Stock

Canada

23 years

2017

231

Financial Results ZYME

ZYME cash flow

Asset, Revenue and Profit Growth - ZYME

ZYME balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions